| Code | CSB-RA023449MB1HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is designed as a research-grade biosimilar to RO-7303509, targeting transforming growth factor beta 3 (TGFB3), a member of the TGF-β superfamily of cytokines. TGFB3 plays critical roles in regulating cell proliferation, differentiation, and extracellular matrix production during embryonic development and tissue homeostasis. This isoform exhibits distinct expression patterns and functions compared to TGFB1 and TGFB2, particularly in wound healing, palatogenesis, and lung development. Dysregulation of TGFB3 signaling has been implicated in fibrotic diseases, cancer progression, and developmental disorders, making it an important target for therapeutic investigation.
RO-7303509 represents a research tool for studying TGFB3-mediated signaling pathways and their contributions to disease pathogenesis. This biosimilar antibody provides researchers with a cost-effective alternative for investigating TGFB3 biology, evaluating its role in fibrosis and tumor microenvironment modulation, and exploring potential therapeutic interventions. The antibody is suitable for various experimental approaches aimed at understanding TGF-β3-specific mechanisms and validating TGFB3 as a therapeutic target in preclinical models.
There are currently no reviews for this product.